Barnett C, Denton BT. Developing near-optimal biomarker-based prostate cancer screening strategies. Presented at the 2016 INFORMS Annual Meeting; November 14, 2016. Nashville, TN.
Barnett C, Merdan S. Data analytics for optimal detection of metastatic prostate cancer. Presented at the 2016 INFORMS Annual Meeting; November 13, 2016. Nashville, TN.
Boye ME, Houghton K, Stull DE. Rethinking what missing patient-reported outcome (PRO) data can teach us about outcomes and survival in oncology clinical trials. Presented at the 2016 ISPOR 19th Annual European Congress; November 1, 2016. Vienna, Austria.
Boysen M, Tyas D, Ling C, Wolowacz S. The new NICE cancer drugs fund technology appraisal process: your questions answered. Presented at the 2016 ISPOR 19th Annual European Congress; October 31, 2016. Vienna, Austria.
Muszbek N, Wolowacz S, Benedict A. Health economic modeling in oncology. Presented at the 2016 ISPOR 19th Annual European Congress; October 31, 2016. Vienna, Austria.
Danysh H, Chi C, Scheurer M, Suzawa H, Woodard T, Kovanci E, Okcu M, Gibbons W, Lupo P. Clinical and genetic predictors of impaired fertility in female survivors of childhood cancer. Presented at the 48th Congress of the International Society of Paediatric Oncology; October 20, 2016. Dublin, Ireland. Previously presented at the American Society of Preventive Oncology 38th Annual Meeting.